Amneal Pharmaceuticals, Inc.
AMRX
$12.60
-$0.18-1.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 77.49% | 1,380.62% | -89.43% | 83.82% | 139.24% |
| Total Depreciation and Amortization | -12.26% | -8.96% | -10.05% | -0.08% | -9.03% |
| Total Amortization of Deferred Charges | 4.71% | -26.14% | -26.84% | 0.94% | -0.09% |
| Total Other Non-Cash Items | -1.07% | -49.32% | 264.87% | -14.73% | -36.30% |
| Change in Net Operating Assets | -1,446.64% | 75.78% | -44.52% | 67.00% | -586.75% |
| Cash from Operations | -120.52% | 10.02% | 41.32% | 1,031.47% | -93.73% |
| Capital Expenditure | 67.89% | -186.84% | 43.21% | -87.66% | 37.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 63.17% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -161.67% | 59.54% | -723.78% | 78.57% | -600.00% |
| Cash from Investing | 52.24% | -102.34% | 15.38% | -49.16% | -10.83% |
| Total Debt Issued | 16,904.15% | -99.97% | -- | -100.00% | -- |
| Total Debt Repaid | -2,199.84% | 99.76% | -16,328.53% | 93.40% | -324.11% |
| Issuance of Common Stock | -93.13% | -15.31% | -4.67% | 892.75% | -54.30% |
| Repurchase of Common Stock | -13,702.18% | -148.84% | 31.75% | 99.13% | -5,491.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -81.74% | 94.23% | -226.99% | -39,069.12% | 98.75% |
| Cash from Financing | -483.55% | -117.02% | 242.59% | -6.44% | 36.01% |
| Foreign Exchange rate Adjustments | -389.47% | 69.88% | -126.06% | 34.68% | 36.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -245.62% | -51.83% | 912.80% | 130.54% | -224.83% |